Has Annie Yang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,985 in general payments to Annie Yang, MD across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Annie Yang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Annie Yang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Annie Yang, MD

Internal Medicine · New York, NYNPI 1396001228

Payments from drug & device makers

$1,985in general payments, 2019–2025

Across 39 payments — averaging $50.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$716
GSK$525
AstraZeneca$311
Janssen Scientific Affairs, LLC$271
Aurinia Pharma U.S., Inc.$97
Johnson & Johnson$64

What the payments were for

Food & beverage$1,985100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	6	$716
GSK	20	$525
AstraZeneca	8	$311
Janssen Scientific Affairs, LLC	2	$271
Aurinia Pharma U.S., Inc.	1	$97
Johnson & Johnson	2	$64

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BENLYSTA$356
Otezla$347
Tremfya$271
Tavneos$244
UPLIZNA$125
SAPHNELO$110

How this compares

$1,985 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Medicare billing

Part B allowed, 2024

$12,460

Medicare patients

Services billed

105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	34	$249,104
MethotrexateMethotrexate Sodium	202	$4,109
Hydroxychloroquine Sulfate	105	$2,484
Celecoxib	89	$1,258
Allopurinol	35	$547
Prednisone	92	$483
Leucovorin Calcium	45	$443
Pilocarpine Hcl	14	$402
Colchicine	18	$316
Meloxicam	19	$42

Paid to pharmacies, not to this prescriber.

Other internal medicine in New York

Helena YuNew York$50.9M
Neha KordeNew York$21.2M
Karen AutioNew York$18.5M
Ingo MellinghoffNew York$16.1M
Gopakumar IyerNew York$12.4M
Sally LauNew York$8.4M
Maria RubinsteinNew York$6.3M
Dana RathkopfNew York$6M
Eytan SteinNew York$5.8M
James GreenwaldNew York$4.9M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →